{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:50:37Z","timestamp":1794639037916,"version":"4.9.1"},"reference-count":191,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ymgme.2023.107525","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T22:30:11Z","timestamp":1674685811000},"page":"107525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource"],"prefix":"10.1016","volume":"138","author":[{"given":"Rebecca L.","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Soler-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget T.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha S.","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Landstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Orhan","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Andrew","family":"Burrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Orthmann-Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deberah S.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surekha","family":"Pendyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeg H.","family":"El-Gharbawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107525_bb0005","series-title":"Carbohydrates: The Essential Molecules of Life (Second Edition)","first-page":"321","article-title":"Chapter 9 - disaccharides, oligosaccharides and polysaccharides","author":"Stick","year":"2009"},{"key":"10.1016\/j.ymgme.2023.107525_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00428-019-02633-6","article-title":"Update on polyglucosan storage diseases","volume":"475","author":"Cenacchi","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ymgme.2023.107525_bb0015","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1093\/hmg\/ddv280","article-title":"Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design","volume":"24","author":"Sean Froese","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107525_bb0020","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3390\/ijms18081743","article-title":"Pathogenesis of Lafora disease: transition of soluble glycogen to insoluble Polyglucosan","author":"Sullivan","year":"2017","journal-title":"Int. J. Mol. Sci.18"},{"key":"10.1016\/j.ymgme.2023.107525_bb0025","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cmet.2013.04.006","article-title":"Hyperphosphorylation of Glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease","volume":"17","author":"Nitschke","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgme.2023.107525_bb0030","series-title":"Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases, Cell Reports","author":"Sullivan","year":"2019"},{"key":"10.1016\/j.ymgme.2023.107525_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/brain\/103.2.315","volume":"103","author":"Robitaille","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2023.107525_bb0040","series-title":"GeneReviews(\u00ae), University of Washington, Seattle Copyright \u00a9 1993\u20132020, University of Washington, Seattle. GeneReviews Is a Registered Trademark of the University of Washington","article-title":"Glycogen storage disease type IV","author":"Magoulas","year":"1993"},{"key":"10.1016\/j.ymgme.2023.107525_bb0045","series-title":"Adult Polyglucosan Body Disease","author":"MedlinePlus","year":"2022"},{"key":"10.1016\/j.ymgme.2023.107525_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.37871\/ajrddt.id17","article-title":"Estimating the prevalence of the adult polyglucosan body disease at the gene level for Ashkenazi Jews in the United States American","volume":"3","author":"Schwartz","year":"2020","journal-title":"J. Rare Disord.: Diagn. Ther."},{"key":"10.1016\/j.ymgme.2023.107525_bb0055","series-title":"Carbohydrate Metabolism","first-page":"28","author":"Andersen","year":"1952"},{"key":"10.1016\/j.ymgme.2023.107525_bb0060","first-page":"11","article-title":"Familial cirrhosis of the liver with storage of abnormal glycogen., Laboratory investigation","author":"Andersen","year":"1956","journal-title":"J. Tech. Methods Pathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0065","series-title":"Type IV Glycogenosis. Report of a Case Proven by Characterization of Glycogen and Studied at Necropsy Bulletin of the Johns Hopkins Hospital","first-page":"157","volume":"111","author":"Sidbury","year":"1962"},{"key":"10.1016\/j.ymgme.2023.107525_bb0070","series-title":"Type IV Glycogenosis Laboratory Investigation","first-page":"357","volume":"15","author":"Holleman","year":"1966"},{"key":"10.1016\/j.ymgme.2023.107525_bb0075","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"725","article-title":"Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis","volume":"56","author":"Brown","year":"1966"},{"key":"10.1016\/j.ymgme.2023.107525_bb0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0387-7604(12)80277-4","article-title":"A mild juvenile variant of type IV glycogenosis","author":"Reusche","year":"1992","journal-title":"Brain and Development"},{"key":"10.1016\/j.ymgme.2023.107525_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3476(87)80341-4","article-title":"Severe cardiopathy in branching enzyme deficiency, the journal of pediatrics","author":"Servidei","year":"1987","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00334454","article-title":"Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis)","volume":"85","author":"Schr\u00f6der","year":"1993","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0022-510X(83)90144-2","article-title":"An adult case of Andersen's disease - type IV glycogenosis. A clinical, histochemical, ultrastructural and biochemical study","volume":"60","author":"Ferguson","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00294181","article-title":"Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis","volume":"87","author":"Tang","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/15513819309048254","article-title":"A congenital variant of glycogenosis type IV","volume":"13","author":"Van Noort","year":"1993","journal-title":"Pediatr. Pathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0110","series-title":"A New Variant of Type IV Glycogenosis: Deficiency of Branching Enzyme Activity without Apparent Progressive Liver Disease Hepatology (Baltimore, Md.)","first-page":"302","volume":"vol. 8","author":"Greene","year":"1988"},{"key":"10.1016\/j.ymgme.2023.107525_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01799348","article-title":"Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease","volume":"19","author":"McConkie-Rosell","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0120","first-page":"292","article-title":"Polysaccharide (amylopectin-like) storage myopathy histochemical","author":"Pellissier","year":"1981","journal-title":"Ultrastruct. Biochem. Stud."},{"key":"10.1016\/j.ymgme.2023.107525_bb0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.410300505","article-title":"Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients","volume":"30","author":"Lossos","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0130","series-title":"GBE1 Adult Polyglucosan Body Disease","author":"Akman","year":"2020"},{"key":"10.1016\/j.ymgme.2023.107525_bb0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ana.23598","article-title":"Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings","volume":"72","author":"Mochel","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10545-017-0103-x","article-title":"A double-blind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome","volume":"41","author":"Schiffmann","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.992406","article-title":"A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum","volume":"13","author":"Kiely","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2023.107525_bb0150","first-page":"217","article-title":"Neural correlates of adaptive working memory training in a glycogen storage disease type-IV patient annals of clinical and translational","volume":"4","author":"Lee","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0155","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.0b013e3181a413fe","article-title":"A 63-year-old woman with urinary incontinence and progressive gait disorder","volume":"72","author":"Lossos","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0160","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1007\/s00415-015-7859-4","article-title":"Frequent misdiagnosis of adult polyglucosan body disease","volume":"262","author":"Hellmann","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2013.4888","article-title":"Branching enzyme deficiency: expanding the clinical spectrum","volume":"71","author":"Paradas","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11910-008-0058-2","article-title":"Normal pressure hydrocephalus: diagnosis and treatment","volume":"8","author":"Shprecher","year":"2008","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/764286","article-title":"Cardiac involvement in glycogen storage disease type IV: two cases and the two ends of a Spectrum","volume":"2012","author":"Aksu","year":"2012","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0180","first-page":"377","article-title":"Hepatocellular carcinoma in an adult patient with type IV glycogen storage disease","volume":"72","author":"Onal","year":"2009","journal-title":"Acta Gastro-Enterol. Belgica"},{"key":"10.1016\/j.ymgme.2023.107525_bb0185","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen storage diseases: new perspectives","volume":"13","author":"Ozen","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0190","doi-asserted-by":"crossref","unstructured":"S.C. Li, C.M. Chen, J.L. Goldstein, J.Y. Wu, E. Lemyre, T.A. Burrow, P.B. Kang, Y.T. Chen, D.S. Bali, Glycogen storage disease type IV: Novel mutations and molecular characterization of a heterogeneous disorder, J. Inherit. Metab. Dis. 33 (2010) Suppl 3:S83-90.","DOI":"10.1007\/s10545-009-9026-5"},{"key":"10.1016\/j.ymgme.2023.107525_bb0195","first-page":"380","article-title":"The clinical and pathological characteristics of a patient with glycogen storage disease IV","volume":"48","author":"Yao","year":"2009","journal-title":"Zhonghua nei ke za zhi [Chin. J. Int. Med.]"},{"key":"10.1016\/j.ymgme.2023.107525_bb0200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jimd.12339","article-title":"The potential of dietary treatment in patients with glycogen storage disease type IV","volume":"44","author":"Derks","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0205","article-title":"Two cases of a non-progressive hepatic form of glycogen storage disease type IV with atypical liver pathology","volume":"24","author":"Ichimoto","year":"2020","journal-title":"Mol. Genet. Metabol. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymgmr.2018.09.001","article-title":"Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review","volume":"17","author":"Iijima","year":"2018","journal-title":"Mol. Genet. Metabol. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0215","doi-asserted-by":"crossref","first-page":"633822","DOI":"10.3389\/fped.2021.633822","article-title":"Liver transplantation for glycogen storage disease type IV","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0220","series-title":"A Novel GBE1 Gene Variant in a Child with Glycogen Storage Disease Type IV, Human Pathology","first-page":"152","author":"Said","year":"2016"},{"key":"10.1016\/j.ymgme.2023.107525_bb0225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MPH.0000000000001694","article-title":"Type IV glycogen storage disease associated with Hemophagocytic Lymphohistiocytosis: a Case report","volume":"42","author":"Wei","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0230","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0235","first-page":"2160","article-title":"Clinical characteristics and gene mutation analysis of one pedigree with glycogen storage disease type IV","volume":"29","author":"Pan","year":"2018","journal-title":"Biomed. Res. (India)"},{"key":"10.1016\/j.ymgme.2023.107525_bb0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/adc.82.6.479","article-title":"Hepatocellular carcinoma in glycogen storage disease type IV","volume":"82","author":"de Moor","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2023.107525_bb0245","series-title":"Polyglucosan Bodies in Placental Extravillious Trophoblast for the Diagnosis of Fatal Perinatal Neuromuscular-Type Glycogen Storage Disease Type IV, Pediatric and Developmental Pathology","first-page":"423","author":"Yu","year":"2018"},{"key":"10.1016\/j.ymgme.2023.107525_bb0250","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/pd.1533","article-title":"Prenatal diagnosis of glycogen storage disease type IV","volume":"26","author":"Akman","year":"2006","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.ymgme.2023.107525_bb0255","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/01.WNL.0000138429.11433.0D","article-title":"Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV)","volume":"63","author":"Bruno","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0260","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1023\/B:BOLI.0000042980.45692.bb","article-title":"Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings","volume":"27","author":"Giuffr\u00e8","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-009-1134-8","article-title":"Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene","volume":"32","author":"Lamperti","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0270","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/0883073811415107","article-title":"Association of the congenital neuromuscular form of glycogen storage disease type IV with a large deletion and recurrent frameshift mutation, journal of child neurology","author":"Li","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005072-199405000-00004","article-title":"Concomitant branching enzyme and phosphorylase deficiencies. An unusual glycogenosis with extensive neuronal polyglucosan storage","volume":"53","author":"Herrick","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0280","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1442-200x.2004.01916.x","article-title":"Congenital form of glycogen storage disease type IV: a case report and a review of the literature","volume":"46","author":"Maruyama","year":"2004","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2023.107525_bb0285","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jpeds.2004.07.024","article-title":"Neonatal type IV glycogen storage disease associated with \u201cnull\u201d mutations in glycogen branching enzyme 1","volume":"145","author":"Janecke","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0290","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1212\/01.WNL.0000073141.61695.B3","article-title":"A neonatal form of glycogen storage disease type IV","volume":"61","author":"Nambu","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00401-008-0417-8","article-title":"Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene","volume":"116","author":"Nolte","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0883073807309248","article-title":"A case of congenital glycogen storage disease type IV with a novel GBE1 mutation","volume":"23","author":"Raju","year":"2008","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0305","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.nmd.2010.07.275","article-title":"Branching enzyme deficiency\/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: muscle biopsy and autopsy findings, biochemical and molecular genetic studies","volume":"20","author":"Taratuto","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0310","first-page":"524","article-title":"Glycogen storage disease type IV: Clinical presentation and diagnosis in a neonate","volume":"67","author":"Massey","year":"2019","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0315","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0042-109399","article-title":"Distinctly elevated Chitotriosidase activity in a child with congenital Andersen disease (glycogen storage disease type IV)","volume":"228","author":"Sch\u00e4nzer","year":"2016","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0320","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mus.21499","article-title":"Non-lethal neonatal neuromuscular variant of glycogenosis type IV with novel GBE1 mutations","volume":"41","author":"Fernandez","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2023.107525_bb0325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/adc.43.229.347","article-title":"Branching enzyme-deficiency glycogenosis: studies in therapy","volume":"43","author":"Fernandes","year":"1968","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2023.107525_bb0330","first-page":"99","article-title":"Glycogen storage disease type IV: a rare cause for neuromuscular disorders or often missed?","volume":"45","author":"Schene","year":"2019","journal-title":"J. Inherited Metab. Dis. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0335","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mus.10520","article-title":"Adult polyglucosan body disease: Case description of an expanding genetic and clinical syndrome","volume":"29","author":"Klein","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2023.107525_bb0340","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.nmd.2015.06.137","article-title":"Unusual demyelinating pathology in a case of adult polyglucosan body disease","volume":"25","author":"Phadke","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0345","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nmd.2014.11.006","article-title":"A novel GBE1 mutation and features of polyglucosan bodies autophagy in adult polyglucosan body disease","volume":"25","author":"Sampaolo","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0350","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/mus.20384","article-title":"Adult polyglucosan body disease: a case report of a manifesting heterozygote","volume":"32","author":"Ubogu","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2023.107525_bb0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","article-title":"The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies","volume":"2","author":"Moses","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0360","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/lt.500010607","article-title":"Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type iv glycogen storage disease","author":"Rosenthal","year":"1995","journal-title":"Liver Transpl. Surg."},{"key":"10.1016\/j.ymgme.2023.107525_bb0365","first-page":"75","article-title":"Neuromuscular forms of glycogen branching enzyme deficiency","volume":"26","author":"Bruno","year":"2007","journal-title":"Acta Myolog."},{"key":"10.1016\/j.ymgme.2023.107525_bb0370","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.410440604","article-title":"Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene","volume":"44","author":"Lossos","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0375","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaneurol.2014.4496","article-title":"Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease","volume":"72","author":"Akman","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0380","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.84.14_supplement.S42.006","article-title":"An exon trap with proper polya site in the GBE1 is the common missing cause in adult polyglucosan body disease","volume":"84","author":"Akman","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0385","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410330114","article-title":"Glycogen branching enzyme deficiency in adult polyglucosan body disease","volume":"33","author":"Bruno","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0390","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5114\/aoms.2018.72246","article-title":"Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficienc. Some discrepancies in genetic and biochemical abnormalities y","volume":"14","author":"Szyma\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0395","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.WNL.0000073144.96680.CB","article-title":"Adult polyglucosan body disease: a postmortem correlation study","volume":"61","author":"Sindern","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0400","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143078","article-title":"C2orf69 mutations disrupt mitochondrial function and cause a multisystem human disorder with recurring autoinflammation","volume":"131","author":"Lausberg","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ymgme.2023.107525_bb0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-3476(88)80121-5","article-title":"Hypoglycemia in type IV glycogenosis: hepatic improvement in two patients with nutritional management","volume":"112","author":"Greene","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0410","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/adc.62.10.1066","article-title":"Dicarboxylic aciduria and secondary carnitine deficiency in glycogenosis type IV","volume":"62","author":"Maaswinkel-Mooy","year":"1987","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2023.107525_bb0415","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1096-8628(19990910)86:2<187::AID-AJMG20>3.0.CO;2-7","article-title":"Early-onset fetal hydrops and muscle degeneration in siblings due to a novel variant of type IV glycogenosis","volume":"86","author":"Cox","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107525_bb0420","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.a.30945","article-title":"Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family","volume":"139 A","author":"L\u2019Hermin\u00e9-Coulomb","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2023.107525_bb0425","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.nmd.2015.01.015","article-title":"Adult polyglucosan body disease: clinical and histological heterogeneity of an Italian family","volume":"25","author":"Colombo","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0430","first-page":"45","article-title":"Glycogen storage diseases: diagnosis, treatment and outcome","volume":"1","author":"Chen","year":"2016","journal-title":"Transl. Sci. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0435","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/01913123.2011.601404","article-title":"Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment","volume":"35","author":"Hicks","year":"2011","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0440","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.humpath.2011.10.001","article-title":"Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review","volume":"43","author":"Magoulas","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0445","first-page":"22","article-title":"An uncommon cause of early infantile liver disease and raised chitotriosidase","volume":"54","author":"Sreekantam","year":"2020","journal-title":"J. Inherited Metab. Dis. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0450","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ajcp\/66.4.702","article-title":"Type IV glycogen storage disease. Light microscopic, electron microscopic, and enzymatic study","volume":"66","author":"Bannayan","year":"1976","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0455","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.gene.2012.12.065","article-title":"Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease","volume":"515","author":"Dainese","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2023.107525_bb0460","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.20285","article-title":"Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease","volume":"20","author":"Krim","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0465","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002340000425","article-title":"Extensive white-matter changes in case of adult polyglucosan body disease","volume":"43","author":"Berkhoff","year":"2001","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0470","first-page":"165","article-title":"Immunohistochemical and ultrastructural changes in the brain in probable adult glycogenosis type IV: adult polyglucosan body disease","volume":"46","author":"Wierzba-Bobrowicz","year":"2008","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0475","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.43.4.785","article-title":"Polyglucosan body disease simulating amyotrophic lateral sclerosis","volume":"43","author":"McDonald","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0031-1276649","article-title":"Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions","volume":"31","author":"Hajdu","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0485","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0889-8529(05)70103-1","article-title":"Glycogen storage disease. Phenotypic, genetic, and biochemical characteristics, and therapy","volume":"28","author":"Wolfsdorf","year":"1999","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.ymgme.2023.107525_bb0490","first-page":"S183","article-title":"A novel mutation of the GBE1 gene in a patient with the non-progressive hepatic form of type IV glycogen storage disease","volume":"38","author":"Ersoy","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0495","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2007.07.074","article-title":"Null mutations and lethal congenital form of glycogen storage disease type IV","volume":"361","author":"Assereto","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2023.107525_bb0500","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.nmd.2003.12.006","article-title":"Fatal infantile neuromuscular presentation of glycogen storage disease type IV","volume":"14","author":"Tay","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0505","series-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases Hepatology (Baltimore, Md.)","first-page":"1014","volume":"vol. 74","author":"Biggins","year":"2021"},{"key":"10.1016\/j.ymgme.2023.107525_bb0510","series-title":"Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases Hepatology (Baltimore, Md.)","first-page":"310","volume":"vol. 65","author":"Garcia-Tsao","year":"2017"},{"key":"10.1016\/j.ymgme.2023.107525_bb0515","first-page":"88","article-title":"Hepatocellular adenoma in glycogen storage disease type IV","volume":"118","author":"Alshak","year":"1994","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0520","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","article-title":"Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?","volume":"46","author":"Demo","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","article-title":"Hepatocellular carcinoma in glycogen storage disease type Ia: a case series","volume":"28","author":"Franco","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0530","doi-asserted-by":"crossref","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen Storage Disease Type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0535","doi-asserted-by":"crossref","unstructured":"P.S. Kishnani, S.L. Austin, J.E. Abdenur, P. Arn, D.S. Bali, A. Boney, W.K. Chung, A.I. Dagli, D. Dale, D. Koeberl, M.J. Somers, S.B. Wechsler, D.A. Weinstein, J.I. Wolfsdorf, M.S. Watson,Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical, Genetics and Genomics, Genet. Med. 16 (2014) e1.","DOI":"10.1038\/gim.2014.128"},{"key":"10.1016\/j.ymgme.2023.107525_bb0540","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230068","article-title":"Glycogen storage disease type IV: Dilated cardiomyopathy as the isolated initial presentation in an adult patient","volume":"12","author":"Ndugga-Kabuye","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0545","first-page":"697","article-title":"Type IV glycogen storage disease: first reported case in Thailand","volume":"72","author":"Hemsrichart","year":"1989","journal-title":"J. Med. Assoc. Thail."},{"key":"10.1016\/j.ymgme.2023.107525_bb0550","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(66)90236-0","article-title":"Cardiomyopathy, cirrhosis of the liver and deposits of a fibrillar polysaccharid. Report of a case with histochemical and electron microscopic studies e","volume":"17","author":"Ferrans","year":"1966","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0555","article-title":"Cardiac involvement in glycogen storage disease type IV: two cases and the two ends of a spectrum case","volume":"2012","author":"Aksu","year":"2012","journal-title":"Rep. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0560","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.WNL.0000073144.96680.CB","article-title":"Adult polyglucosan body disease: a postmortem correlation study","volume":"61","author":"Sindern","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb0565","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/oxfordjournals.eurheartj.a060797","article-title":"A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy","volume":"16","author":"Nase","year":"1995","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymgme.2023.107525_bb0570","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s003920050361","article-title":"Glycogenosis type IV as a seldom cause of cardiomyopathy - report about a successful heart transplantation","volume":"88","author":"Ewert","year":"1999","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230068","article-title":"Glycogen storage disease type IV: dilated cardiomyopathy as the isolated initial presentation in an adult patient","volume":"12","author":"Ndugga-Kabuye","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa078","article-title":"Case report: adult-onset manifesting heterozygous glycogen storage disease type IV with dilated cardiomyopathy and absent late gadolinium enhancement on cardiac magnetic resonance imaging","volume":"4","author":"Lyo","year":"2020","journal-title":"Eur. Heart J. - Case Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0585","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","article-title":"Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines","volume":"29","author":"Kantor","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0590","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"issue":"2020","key":"10.1016\/j.ymgme.2023.107525_bb0595","first-page":"e558","article-title":"AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"2017","key":"10.1016\/j.ymgme.2023.107525_bb0600","article-title":"ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2023.107525_bb0605","series-title":"American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Hepatology (Baltimore, Md.)","first-page":"362","article-title":"Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases","volume":"vol. 60","author":"Squires","year":"2014"},{"key":"10.1016\/j.ymgme.2023.107525_bb0610","first-page":"772","article-title":"Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genetics and Genomics (ACMG), Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0615","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-3046.2007.00803.x","article-title":"Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk\/benefit of this procedure","volume":"12","author":"Davis","year":"2008","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2023.107525_bb0620","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1007\/BF02072093","article-title":"Liver transplantation for type I and type IV glycogen storage disease","volume":"152","author":"Selby","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0625","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199303183281101","article-title":"Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher\u2019s disease","author":"Starzl","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0630","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13023-022-02284-y","article-title":"Liver transplantation in glycogen storage disease: a single-center experience","volume":"17","author":"Beyzaei","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0635","first-page":"S353","article-title":"Living donor liver transplantation for glycogen storage disease type IV; a case report","volume":"9","author":"Bostanci","year":"2015","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ymgme.2023.107525_bb0640","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/lt.500010607","article-title":"Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease","volume":"1","author":"Rosenthal","year":"1995","journal-title":"Liver Transplant. Surg."},{"key":"10.1016\/j.ymgme.2023.107525_bb0645","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MPG.0b013e3181d29780","article-title":"Systemic progression of type IV glycogen storage disease after liver transplantation","volume":"51","author":"Willot","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0655","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.transproceed.2006.10.018","article-title":"Nesiritide as bridge to multi-organ transplantation: a Case report","volume":"39","author":"Cochrane","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ymgme.2023.107525_bb0660","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-3476(72)80144-6","article-title":"Glycogenosis IV: a new cause of infantile hypotonia","volume":"80","author":"Zellweger","year":"1972","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0665","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI118517","article-title":"Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene","volume":"97","author":"Bao","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ymgme.2023.107525_bb0670","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/ajmg.a.31166","article-title":"Non-lethal congenital hypotonia due to glycogen storage disease type IV","volume":"140 A","author":"Burrow","year":"2006","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107525_bb0675","series-title":"A Novel Neuromuscular Form of Glycogen Storage Disease Type IV with Arthrogryposis, Spinal Stiffness and Rare Polyglucosan Bodies in Muscle, Neuromuscular Disorders","first-page":"681","author":"Malfatti","year":"2016"},{"key":"10.1016\/j.ymgme.2023.107525_bb0680","first-page":"51","article-title":"Case of neonatal fatality from neuromuscular variant of glycogen storage disease type IV","author":"Sandhu","year":"2019","journal-title":"J. Inherited Metab. Dis. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0685","first-page":"S204","article-title":"Glycogen storage disease type iv presenting as congenital myopathy with contractures and rigid spine","volume":"5","author":"Walter","year":"2018","journal-title":"J. Neuromusc. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0690","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jimd.12325","article-title":"GBE1-related disorders: adult polyglucosan body disease and its neuromuscular phenotypes","volume":"44","author":"Souza","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0695","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1007\/s00415-022-10960-z","article-title":"Characterization of cognitive impairment in adult polyglucosan body disease","volume":"269","author":"Zebhauser","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0700","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2012.10.015","article-title":"Acute but transient neurological deterioration revealing adult polyglucosan body disease","volume":"324","author":"Billot","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0705","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jns.2017.06.019","article-title":"New genetic causes for complex hereditary spastic paraplegia","volume":"379","author":"Souza","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0710","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/WAD.0b013e31821cc65d","article-title":"Adult polyglucosan body disease masquerading as \u201cALS with dementia of the Alzheimer type\u201d: an exceptional phenotype in a rare pathology","volume":"26","author":"Segers","year":"2012","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ymgme.2023.107525_bb0715","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/jnnp.65.5.788","article-title":"Adult polyglucosan body disease associated with an extrapyramidal syndrome","volume":"65","author":"Robertson","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2023.107525_bb0720","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archneur.60.5.764","article-title":"Adult polyglucosan body disease associated with Lewy bodies and tremor","volume":"60","author":"Trivedi","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0725","first-page":"227","article-title":"Familial dementia due to adult polyglucosan body disease","volume":"16","author":"Bigio","year":"1997","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0730","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/nan.12144","article-title":"Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration","volume":"40","author":"Bit-Ivan","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0735","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF00867422","article-title":"Dementia of frontal lobe type due to adult polyglucosan body disease","volume":"242","author":"Boulan-Predseil","year":"1995","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0740","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/13554794.2011.654217","article-title":"Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions","volume":"19","author":"Farmer","year":"2013","journal-title":"Neurocase"},{"key":"10.1016\/j.ymgme.2023.107525_bb0745","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/mus.25041","article-title":"Adult polyglucosan body disease presenting as a unilateral progressive plexopathy","volume":"53","author":"Naddaf","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2023.107525_bb0755","article-title":"Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease neurology","volume":"3","author":"Harigaya","year":"2017","journal-title":"Genetics"},{"key":"10.1016\/j.ymgme.2023.107525_bb0760","first-page":"A278","article-title":"An unexpected case of adult polyglucosan body disease","volume":"38","author":"Nicholaus","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0765","first-page":"632","article-title":"Intriguing mixed pathologic features in a Case of dementia with Lewy bodies the","volume":"119","author":"Balin","year":"2019","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.ymgme.2023.107525_bb0770","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2020-325437","article-title":"Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases","volume":"92","author":"Grunseich","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2023.107525_bb0775","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00005072-198807000-00007","article-title":"Adult polyglucosan body disease (APBD)","volume":"47","author":"Gray","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0780","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.23854","article-title":"Childhood presentation of \u201cadult\u201d polyglucosan body disease: Normal GBE1 sequence with no glycogen branching enzyme activity","volume":"73","author":"Bathgate","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0785","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mus.20916","article-title":"Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene","volume":"37","author":"Massa","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2023.107525_bb0790","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/JU.0000000000002235","article-title":"The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J. Urol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0795","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J. Urol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0800","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sc.2009.134","article-title":"Urethral versus suprapubic catheter: choosing the best bladder management for male spinal cord injury patients with indwelling catheters","volume":"48","author":"Katsumi","year":"2010","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ymgme.2023.107525_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094440","article-title":"Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: implications for early and differential diagnosis","volume":"22","author":"Menculini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0810","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/brain\/awx115","article-title":"Transdiagnostic neurology: neuropsychiatric symptoms in neurodegenerative diseases","volume":"140","author":"Husain","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2023.107525_bb0815","doi-asserted-by":"crossref","first-page":"877","DOI":"10.30773\/pi.2019.0106","article-title":"Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art","volume":"16","author":"Silveira","year":"2019","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.ymgme.2023.107525_bb0820","first-page":"385","article-title":"Psychological distress in patients with Charcot-Marie-tooth disease","volume":"45","author":"Vinci","year":"2009","journal-title":"Eur. J. Phys. Rehab. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0825","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10545-006-0290-3","article-title":"Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential","volume":"29","author":"Roe","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0830","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ymgme.2010.06.017","article-title":"Adult Polyglucosan body disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways","volume":"101","author":"Roe","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107525_bb0835","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/07315724.2019.1695233","article-title":"Triheptanoin supplementation does not affect nutritional status: a Case report of two siblings with adult polyglucosan body disease","volume":"39","author":"De Amicis","year":"2020","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ymgme.2023.107525_bb0840","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0002-8223(93)92246-T","article-title":"Nutrition therapy for hepatic glycogen storage diseases","author":"Goldberg","year":"1993","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ymgme.2023.107525_bb0845","article-title":"Section on, policy statement: breastfeeding and the use of Human Milk","volume":"150","author":"Meek","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2023.107525_bb0850","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archpedi.1995.02170190068012","article-title":"Use of segmental measures to estimate stature in children with cerebral palsy","volume":"149","author":"Stevenson","year":"1995","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0855","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s10072-021-05096-3","article-title":"Adult polyglucosan body disease\u2014an atypical compound heterozygous with a novel GBE1 mutation","volume":"42","author":"Carvalho","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0860","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-immunol-093019-124155","article-title":"The ins and outs of central nervous system inflammation-lessons learned from multiple sclerosis","volume":"39","author":"Ramaglia","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0865","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/glia.22737","article-title":"Adapting brain metabolism to myelination and long-range signal transduction","volume":"62","author":"Hirrlinger","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2023.107525_bb0870","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1083\/jcb.201702150","article-title":"Regulation and dysregulation of axon infrastructure by myelinating glia","volume":"216","author":"Pan","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0875","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymgme.2023.107525_bb0880","series-title":"Glia as Architects of Central Nervous System Formation and Function Science (New York, N.Y.)","first-page":"181","volume":"vol. 362","author":"Allen","year":"2018"},{"key":"10.1016\/j.ymgme.2023.107525_bb0885","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","article-title":"Microglia in multiple sclerosis: friend or foe?","volume":"11","author":"Guerrero","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2023.107525_bb0890","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s13311-022-01218-7","article-title":"AAV-mediated artificial miRNA reduces pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and lafora disease mouse models","volume":"19","author":"Gumusgoz","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymgme.2023.107525_bb0895","series-title":"Alglucosidase Alfa Treatment Alleviates Liver Disease in a Mouse Model of Glycogen Storage Disease Type IV, Molecular Genetics and Metabolism Reports","first-page":"31","author":"Yi","year":"2016"},{"key":"10.1016\/j.ymgme.2023.107525_bb0900","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2016.099","article-title":"Systemic correction of murine glycogen storage disease type IV by an AAV-mediated gene therapy","volume":"28","author":"Yi","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107525_bb0905","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99694","article-title":"Guaiacol as a drug candidate for treating adult polyglucosan body disease","volume":"3","author":"Kakhlon","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2023.107525_bb0910","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114554","article-title":"Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism","volume":"13","author":"Kakhlon","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0915","first-page":"63","article-title":"A rare cause of elevated chitotriosidase activity: Glycogen storage disease type IV","volume":"17","author":"Hizarcioglu-Gulsen","year":"2014","journal-title":"J. Inherited Metab. Dis. Rep."},{"key":"10.1016\/j.ymgme.2023.107525_bb0920","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/B:BOLI.0000043025.17721.fc","article-title":"The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update","volume":"27","author":"Michelakakis","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107525_bb0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(88)90172-6","article-title":"Urinary excretion of a glucose-containing tetrasaccharide: a parameter for increased degradation of glycogen","volume":"176","author":"Kumlien","year":"1988","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2023.107525_bb0930","first-page":"50","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques American journal of medical genetics part C: seminars in medical","volume":"160c","author":"Young","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.ymgme.2023.107525_bb0935","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41436-019-0561-7","article-title":"Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring","volume":"21","author":"Halaby","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0940","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41436-020-0878-2","article-title":"The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases","volume":"22","author":"Heiner-Fokkema","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107525_bb0945","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in pompe disease and other glycogen storage diseases","volume":"58","author":"Sluiter","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2023.107525_bb9188","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mus.880140203","article-title":"Polyglucosan body disease","volume":"14","author":"Cafferty","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2023.107525_bb9189","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.410130411","article-title":"Adult polyglucosan body disease: Clinical and nerve biopsy findings in two cases","volume":"13","author":"Vos","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.ymgme.2023.107525_bb9190","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/BF03013436","article-title":"Sevoflurane anaesthesia for a patient with adult polyglucosan body disease","volume":"43","author":"Inoue","year":"1996","journal-title":"Canadian Journal of Anaesthesia"},{"key":"10.1016\/j.ymgme.2023.107525_bb9191","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting gys1 with AAV\u2010SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T01:54:55Z","timestamp":1728784495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":191,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1096719223001555"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107525","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107525"}}